Live tape
Top 8, mentions 7d11,472SPCX2,433 mentions▲ +0.08GOOGL1,988 mentions▲ +0.02META1,794 mentions▲ +0.04TSLA1,707 mentions▲ +0.05NFLX973 mentions▲ +0.03QQQ888 mentions▲ +0.04AMZN847 mentions▲ +0.06NVDA842 mentions▲ +0.06

Equity · Financial Services

OACC

NASDAQ

Oaktree Acquisition Corp. III Life Sciences (OACC)

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for OACC to draw a line in its place.

Track this symbol on TradingView TradingView chart

Oaktree Acquisition Corp. III Life Sciences (OACC) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 23 Oct 2026

In the 90 days to 26 Oct 2026, no Oaktree Acquisition Corp. III Life Sciences insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
23 Oct 2026 Oaktree Acquisition Holdings III LS, LLC 10% Owner Other 4,798,758

Oaktree Acquisition Corp. III Life Sciences (OACC) reported financials

SEC EDGAR XBRL SEC EDGAR

Oaktree Acquisition Corp. III Life Sciences reported net income of $7.3M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income $7.3M 31 Dec 2025 fiscal year
Total assets $206.5M 30 Jun 2026 at period end
Total equity −$7.5M 30 Jun 2026 at period end

Oaktree Acquisition Corp. III Life Sciences (OACC) institutional holders (13F)

SEC Form 13F SEC EDGAR

3 of the 45 institutional funds we track reported a Oaktree Acquisition Corp. III Life Sciences position for the quarter ended 30 Jun 2026 — a combined $15.8M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) 861,625 $9.2M
Two Sigma Investments Held (±25%) 437,500 $4.7M
Millennium Management Held (±25%) 175,000 $1.9M
Citadel Advisors Exited

Oaktree Acquisition Corp. III Life Sciences (OACC): frequently asked questions

From live data

Have Oaktree Acquisition Corp. III Life Sciences insiders bought or sold shares recently?

In the 90 days to 26 Oct 2026, no Oaktree Acquisition Corp. III Life Sciences insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

How many institutions hold Oaktree Acquisition Corp. III Life Sciences?

3 of the 45 institutional funds we track reported a Oaktree Acquisition Corp. III Life Sciences position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

What exchange is Oaktree Acquisition Corp. III Life Sciences listed on?

Oaktree Acquisition Corp. III Life Sciences trades on NASDAQ under the ticker OACC.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. TradingViewthe price chart widget, drawn by TradingView from their own data
  2. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  3. SEC EDGARSEC EDGAR 13F filings